Clinical outcomes and frequency of persistent infection among immunosuppressed patients treated with bebtelovimab for COVID-19 infection at an ambulatory cancer center.
Sanchez E, Krantz EM, Yoke L, Gallaher M, Bhattacharyya P, So L, Escobar ZK, Tverdek F, Rosen EA, Quinn ZZ, Swetky M, Walji S, Wilson MH, McCreery B, McCulloch D, Weixler A, Roychoudhury P, Pergam SA, Liu C.
Sanchez E, et al. Among authors: krantz em.
Transpl Infect Dis. 2024 Feb;26(1):e14223. doi: 10.1111/tid.14223. Epub 2024 Jan 8.
Transpl Infect Dis. 2024.
PMID: 38191852
Review.